These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Treatment of chronic human Chagas disease with itraconazole and allopurinol. Preliminary report]. Apt W; Aguilera X; Arribada A; Pérez C; Miranda C; Zulantay I; Apt P; Cortés P; Rodríguez J Rev Med Chil; 1994 Apr; 122(4):420-7. PubMed ID: 7809537 [TBL] [Abstract][Full Text] [Related]
7. [Immune response to Trypanosoma cruzi. An approach to the pathogenesis of Chagas' disease]. Braun M; de Titto E Acta Physiol Pharmacol Latinoam; 1985; 35(1):1-47. PubMed ID: 2932884 [TBL] [Abstract][Full Text] [Related]
8. Effects of specific treatment on parasitological and histopathological parameters in mice infected with different Trypanosoma cruzi clonal genotypes. Toledo MJ; Bahia MT; Veloso VM; Carneiro CM; Machado-Coelho GL; Alves CF; Martins HR; Cruz RE; Tafuri WL; Lana M J Antimicrob Chemother; 2004 Jun; 53(6):1045-53. PubMed ID: 15102747 [TBL] [Abstract][Full Text] [Related]
9. Trypanosoma cruzi: dehydroepiandrosterone (DHEA) and immune response during the chronic phase of the experimental Chagas' disease. Caetano LC; Santello FH; Del Vecchio Filipin M; Brazão V; Caetano LN; Toldo MP; Caldeira JC; do Prado Júnior JC Vet Parasitol; 2009 Jul; 163(1-2):27-32. PubMed ID: 19446400 [TBL] [Abstract][Full Text] [Related]
10. Use of polymerase chain reaction (PCR) and hybridization assays to detect Trypanosoma cruzi in chronic chagasic patients treated with itraconazole or allopurinol. Zulantay I; Honores P; Solari A; Apt W; Ortiz S; Osuna A; Rojas A; López B; Sánchez G Diagn Microbiol Infect Dis; 2004 Apr; 48(4):253-7. PubMed ID: 15062917 [TBL] [Abstract][Full Text] [Related]
16. [Study of cases of leishmaniasis in the Province of Salta: evidences of mixed infection with Trypanosoma cruzi and Leishmania spp]. Chiaramonte MG; Zwirner NW; Caropresi SL; Heredia V; Taranto NJ; Malchiodi EL Medicina (B Aires); 1996; 56(3):259-68. PubMed ID: 9035482 [TBL] [Abstract][Full Text] [Related]
17. Treatment of Chagas' disease with itraconazole: electrocardiographic and parasitological conditions after 20 years of follow-up. Apt W; Arribada A; Zulantay I; Rodríguez J; Saavedra M; Muñoz A J Antimicrob Chemother; 2013 Sep; 68(9):2164-9. PubMed ID: 23645584 [TBL] [Abstract][Full Text] [Related]
18. In vivo studies of 5-arylethenylbenzofuroxans in acute murine models of Chagas' disease. Boiani L; Davies C; Arredondo C; Porcal W; Merlino A; Gerpe A; Boiani M; Pacheco JP; Basombrío MA; Cerecetto H; González M Eur J Med Chem; 2008 Oct; 43(10):2229-37. PubMed ID: 18255195 [TBL] [Abstract][Full Text] [Related]
19. Trypanosoma cruzi calreticulin: a possible role in Chagas' disease autoimmunity. Ribeiro CH; López NC; Ramírez GA; Valck CE; Molina MC; Aguilar L; Rodríguez M; Maldonado I; Martínez R; González C; Troncoso R; Lavandero S; Gingras AR; Schwaeble W; Ferreira A Mol Immunol; 2009 Mar; 46(6):1092-9. PubMed ID: 19108895 [TBL] [Abstract][Full Text] [Related]
20. Dissimilar distribution of Trypanosoma cruzi clones in humans after chemotherapy with allopurinol and itraconazole. Coronado X; Zulantay I; Rozas M; Apt W; Sánchez G; Rodríguez J; Ortiz S; Solari A J Antimicrob Chemother; 2006 Jul; 58(1):216-9. PubMed ID: 16717054 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]